Predict your next investment

Calvert Research company logo
HEALTHCARE | Pharmaceuticals / Drugs
calvert-research.com

See what CB Insights has to offer

About Calvert Research

Calvert Research is a strategic advisory and equity investment firm with experience in preclinical drug development. Its knowledge base covers all aspects related to advancing early stage drug candidates toward human clinical testing such as drug manufacturing, drug product formulation, analytical/bioanalytical methods development and animal safety, toxicology, pharmacology, immunology, and pharmacokinetic testing. It offers a range of preclinical services through its CRO affiliate, Calvert Laboratories, in addition to subcontractors to design and execute customized drug development partnership programs with preclinical stage biopharmaceutical companies.

Calvert Research Headquarter Location

1225 Crescent Green Suite 115

Cary, North Carolina, 27518,

United States

919-459-8653

Latest Calvert Research News

Tesla Shareholders Appear to Pass Calvert’s Diversity Proposal

Oct 8, 2021

08 Oct 2021, 7:52 AM IST 08 Oct 2021, 6:40 AM IST 08 Oct 2021, 7:52 AM IST Save (Bloomberg) -- A shareholder resolution asking Tesla Inc. to provide more quantitative, comparable data about its diversity, equity and inclusion efforts appeared to pass based on preliminary results at the company’s annual meeting Thursday. (Bloomberg) -- A shareholder resolution asking Tesla Inc. to provide more quantitative, comparable data about its diversity, equity and inclusion efforts appeared to pass based on preliminary results at the company’s annual meeting Thursday. Calvert Research & Management put forward resolution number six, which asks Tesla to fully disclose its workforce by race and gender according to data collected by the U.S. “We ask that Tesla disclose its full EE0-1 report,” Kimberly Stokes of Calvert said at the meeting, which was held at the electric carmaker’s new factory in Austin, Texas. “Tesla’s disclosure lags far behind peers.”  Stokes couldn’t immediately be reached for comment late Thursday.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.